Download Free Sample Report

The global Engineered Cell Therapy market was valued at US$ 4352.5 million in 2023 and is projected to reach US$ 10496.2 million by 2030, at a CAGR of 13.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Synthetic Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Engineered Cell Therapy include Medtronic, Stryker, Zimmer Inc., Acelity, Allergan, Cook Medical, Baxter International, Organovo Holdings Inc and Integra LifeSciences, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Engineered cell therapy is designed to improve the ability of a patient's immune system to fight cancer by reintroducing improved immune cells. They are manufactured by collecting specific immune cells, called T cells, from the blood of the patient.
This report aims to provide a comprehensive presentation of the global market for Engineered Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Engineered Cell Therapy. This report contains market size and forecasts of Engineered Cell Therapy in global, including the following market information:

• Global Engineered Cell Therapy Market Revenue, 2019-2024, 2025-2030, ($ millions)
• Global top five companies in 2023 (%)

We surveyed the Engineered Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Engineered Cell Therapy Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Engineered Cell Therapy Market Segment Percentages, by Type, 2023 (%)

• Synthetic
• Biologically Derived
• Others

Global Engineered Cell Therapy Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Engineered Cell Therapy Market Segment Percentages, by Application, 2023 (%)

• Research Institutes
• Biotechnological Organizations
• Diagnostic Centres

Global Engineered Cell Therapy Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Engineered Cell Therapy Market Segment Percentages, By Region and Country, 2023 (%)

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
• The Middle East and Africa (Middle East, Africa)
• South and Central America (Brazil, Argentina, Rest of SCA)

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies Engineered Cell Therapy revenues in global market, 2019-2024 (estimated), ($ millions)

Key companies Engineered Cell Therapy revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:

• Medtronic
• Stryker
• Zimmer Inc.
• Acelity
• Allergan
• Cook Medical
• Baxter International
• Organovo Holdings Inc
• Integra LifeSciences
• DePuy Synthes
• B. Braun Melsungen AG
• AbbVie
• Becton
• Dickinson and Company
• Organogenesis Inc.
• Athersys Inc.
• ReproCell Inc.
• RTI Surgical Inc.
• Tissue Regenix Group Plc
• RepliCel.

Outline of Major Chapters:
Chapter 1: Introduces the definition of Engineered Cell Therapy, market overview.
Chapter 2: Global Engineered Cell Therapy market size in revenue.
Chapter 3: Detailed analysis of Engineered Cell Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Engineered Cell Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.